Pharmacotherapeutic group: Stomatological preparations, agents for the prevention of dental caries, ATC code: A01AA01.
Mechanism of action:
Sodium fluoride increases the resistance of the teeth to dental caries. Tooth enamel thus becomes more resistant to the acids produced by the bacteria of dental plaque. Sodium fluoride enables remineralisation of the teeth and reduces microbial acid production. Fluoridation should begin before the teeth erupt and should continue throughout life. Before the teeth erupt, fluoride reaches the developing teeth via the bloodstream, allowing effective fluoridation even before eruption. After eruption, the teeth receive fluoride through direct contact with the fluoride contained in saliva.
Warnings
In patients with impaired renal function, the product should be administered only after consultation with the treating physician.
When fluoride is administered, the amount of fluoride the individual receives from other sources must be known in order to avoid overdose. Where fluoridation of table salt and water occurs, the dose of Zymafluor must be reduced. If the water contains more than 0.7 mg/l of fluoride, further fluoride administration is not recommended.
Information on the excipients of the product:
Sorbitol
This medicinal product contains 38 mg of sorbitol per tablet. The additive effect of concomitantly administered products containing sorbitol (or fructose) and the dietary intake of sorbitol (or fructose) should be taken into account.
The sorbitol content of medicinal products for oral use may affect the bioavailability of other concomitantly administered medicinal products taken orally.
Patients with hereditary fructose intolerance (HFI) should not take this medicinal product.
Sodium
This medicinal product contains less than 1 mmol (23 mg) of sodium per tablet, that is to say essentially "sodium-free".
